A new, rapid, fully automated method for determination of fluconazole in serum by column-switching liquid chromatography

被引:18
作者
Egle, H
Trittler, R
Kümmerer, K
机构
[1] Univ Hosp Freiburg, Inst Environm Med, D-79106 Freiburg, Germany
[2] Univ Hosp Freiburg, Hosp Epidemiol, D-79106 Freiburg, Germany
关键词
fluconazole; column switching; in-line extraction; drug monitoring;
D O I
10.1097/00007691-200408000-00013
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A sensitive and rapid HPLC assay for the determination of fluconazole in serum is described. HPLC-integrated sample preparation allows direct injection of serum samples without any pretreatment. The in-line extraction technique is carried out by automatically switching from the extraction column (Lichrospher(R) ADS C-8) to the analytic column (Nucleosil C-18). After 6 minutes the matrix passes the extraction column, and the retained analyte is quantitatively transferred to the analytic column, where separation by isocratic HPLC is performed. The extraction eluent is sodium dihydrogen phosphate buffer, pH 5.0 (50 mM). and the analytic eluent is acetonitrile/sodium dihydrogen phosphate buffer, pH 5.0 (50 mM) (26.8/73.2, vol/vol). Fluconazole is detected according to its absorption maximum at 210 nm. The lower limit of quantification (LLOQ) is 0.65 mug/mL, the limit of detection (LOD) is 0.2 mug/mL, and the quantification range is 0.65-23.3 mug/mL. The assay was precise with a between-run coefficient of variation of less than or equal to 5.59%. The within-run accuracy was 99.8% and 103.4%, and the between-run accuracy was 99.2% and 99.7%, respectively, for the concentrations 23.3 mug/mL and 1.3 mug/mL. The recovery was 78%. The described procedure allows sample cleanup and determination within 20 minutes, thereby facilitating drug monitoring in clinical routine. The method was applied successfully.
引用
收藏
页码:425 / 431
页数:7
相关论文
共 36 条
[1]   INDUCTION OF FLUCONAZOLE METABOLISM BY RIFAMPIN - INVIVO STUDY IN HUMANS [J].
APSELOFF, G ;
HILLIGOSS, DM ;
GARDNER, MJ ;
HENRY, EB ;
INSKEEP, PB ;
GERBER, N ;
LAZAR, JD .
JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) :358-361
[2]   ALKYL-DIOL SILICA (ADS) - RESTRICTED ACCESS PRECOLUMN PACKINGS FOR DIRECT-INJECTION AND COUPLED-COLUMN CHROMATOGRAPHY OF BIOFLUIDS [J].
BOOS, KS ;
RUDOLPHI, A ;
VIELHAUER, S ;
WALFORT, A ;
LUBDA, D ;
EISENBEISS, F .
FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY, 1995, 352 (7-8) :684-690
[3]  
*BUND PHARM IND EV, 2000, FACH DIFL
[4]   High-performance liquid chromatographic determination of fluconazole in plasma [J].
Cociglio, M ;
Brandissou, S ;
Alric, R ;
Bressolle, F .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 686 (01) :11-17
[5]  
Cohen LG, 1997, PHARMACOTHERAPY, V17, P1023
[6]   CLINICAL PHARMACOKINETICS OF FLUCONAZOLE [J].
DEBRUYNE, D ;
RYCKELYNCK, JP .
CLINICAL PHARMACOKINETICS, 1993, 24 (01) :10-27
[7]   A new and rapid method for monitoring the new oxazolidinone antibiotic linezolid in serum and urine by high performance liquid chromatography-integrated sample preparation [J].
Ehrlich, M ;
Trittler, R ;
Daschner, FD ;
Kümmerer, K .
JOURNAL OF CHROMATOGRAPHY B, 2001, 755 (1-2) :373-377
[8]   Rapid antibiotic drug monitoring:: Meropenem and ceftazidime determination in serum and bronchial secretions by high-performance liquid chromatography-integrated sample preparation [J].
Ehrlich, M ;
Daschner, FD ;
Kümmerer, K .
JOURNAL OF CHROMATOGRAPHY B, 2001, 751 (02) :357-363
[9]   Variability of plasma fluconazole levels in patients with hematologic malignancy [J].
Ellis, ME ;
Spence, D ;
Ernst, P ;
Greer, W .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (01) :86-87
[10]   Unusual outcome of disseminated candidiasis treated with fluconazole:: A matter of pharmacokinetics? [J].
Faucher, JF ;
Thiébaut, MM ;
Reynes, J ;
Janbon, F .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :197-198